Placebo ODT
Sponsors
Flex Pharma, Inc., Ferring Pharmaceuticals, NYU Langone Health, Kadence Bio
Conditions
Charcot-Marie-Tooth DiseaseMotor Neuron DiseaseNocturiaPain, PostoperativePremature Ejaculation
Phase 2
A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.
TerminatedNCT03196375
Start: 2017-07-28End: 2018-07-27Updated: 2018-08-29
A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults
CompletedNCT03201419
Start: 2017-07-27End: 2019-10-31Updated: 2022-03-02
A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps.
TerminatedNCT03254199
Start: 2017-10-16End: 2018-07-27Updated: 2018-08-29
The Use of Cannabidiol (CBD) in Pain Reduction and Opioid Use After Shoulder Arthroscopy
CompletedNCT04672252
Start: 2020-12-01End: 2022-12-16Updated: 2023-03-07
Study to Evaluate the Potential Effects of KH-001 on Intravaginal Ejaculatory Latency Time (IELT), Patient-Reported Outcomes, and Safety in Men With Lifelong Premature Ejaculation (LPE)
RecruitingNCT07434271
Start: 2025-12-01End: 2026-08-30Target: 40Updated: 2026-02-25